Modulation of aggressive behavior in mice by nicotinic receptor subtypes

Biochemical Pharmacology

Volumn 97, Issue 4, 2015, Pages 488-497

  Lewis, Alan S ^a   Mineur, Yann S ^a   Smith, Philip H ^a   Cahuzac, Emma L M ^a   Picciotto, Marina R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aggression; GTS 21 DMXB a7; Nicotine; Nicotinic acetylcholine receptor

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ACETYLCHOLINE; BUNGAROTOXIN RECEPTOR; DIHYDRO BETA ERYTHROIDINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR; SERENIC AGENT; ACONITINE; NICOTINIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT;

AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MALE; MOUSE; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; SOCIAL INTERACTION; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL BEHAVIOR; BAGG ALBINO MOUSE; C57BL MOUSE; DRUG EFFECTS; METABOLISM;

ACONITINE; AGGRESSION; ANIMALS; BEHAVIOR, ANIMAL; DIHYDRO-BETA-ERYTHROIDINE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC;

EID: 84943350610     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2015.07.019     Document Type: Article

References (68)

1. B.A. Adler, L.K. Wink, M. Early, R. Shaffer, N. Minshawi, C.J. McDougle, and et al. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study Autism 19 2015 102 106
2. D.T. Maust, H.M. Kim, L.S. Seyfried, C. Chiang, J. Kavanagh, L.S. Schneider, and et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm JAMA Psychiatry 72 2015 438 445
3. L. Citrome, and J. Volavka Pharmacological management of acute and persistent aggression in forensic psychiatry settings CNS Drugs 25 2011 1009 1021
4. R. Yanowitch, and E.F. Coccaro The neurochemistry of human aggression Adv. Genet. 75 2011 151 169
5. S. Wonnacott, J. Barik, J. Dickinson, and I.W. Jones Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters J. Mol. Neurosci. 30 2006 137 140
6. M.R. Picciotto, A.S. Lewis, G.I. van Schalkwyk, and Y.S. Mineur Mood and anxiety regulation by nicotinic acetylcholine receptors: a potential pathway to modulate aggression and related behavioral states Neuropharmacology 96 2015 235 243
7. G.G. Berntson, M.S. Beattie, and J.M. Walker Effects of nicotinic and muscarinic compounds on biting attack in the cat Pharmacol. Biochem. Behav. 5 1976 235 239
8. A.P. Silverman Behaviour of rats given a "smoking dose" of nicotine Anim. Behav. 19 1971 67 74
9. M.D. Schechter Effect of nicotine on response to frustrative non-reward in the rat Eur. J. Pharmacol. 29 1974 312 315
10. R.J. Rodgers Effects of nicotine, mecamylamine, and hexamethonium on shock-induced fighting, pain reactivity, and locomotor behaviour in rats Psychopharmacology 66 1979 93 98
11. P. Driscoll, and K. Baettig Selective inhibition by nicotine of shock-induced fighting in the rat Pharmacol. Biochem. Behav. 14 1981 175 179
12. R.J. Waldbillig Suppressive effects of intraperitoneal and intraventricular injections of nicotine on muricide and shock-induced attack on conspecifics Pharmacol. Biochem. Behav. 12 1980 619 623
13. S.K. Johnson, K.M. Carlson, J. Lee, L.E. Burr, and G.C. Wagner Effects of nicotine on target biting and resident-intruder attack Life Sci. 2003 311 317
14. H. Carmel, and B.B. Sheitman Adjunctive transdermal nicotine reduced behavioral agitation in severe dementia Am. J. Geriatr. Psychiatry 15 2007 449
15. R.A. Rosin, M.D. Levine, and E. Peskind Transdermal nicotine for agitation in dementia Am. J. Geriatr. Psychiatry 9 2001 443 444
16. G.I. Van Schalkwyk, A.S. Lewis, Z. Qayyum, K. Koslosky, M.R. Picciotto, and F.R. Volkmar Reduction of aggressive episodes after repeated transdermal nicotine administration in a hospitalized adolescent with autism spectrum disorder J. Autism Dev. Disord. 2015 [Epub ahead of print]
17. S.G. Matta, D.J. Balfour, N.L. Benowitz, R.T. Boyd, J.J. Buccafusco, A.R. Caggiula, and et al. Guidelines on nicotine dose selection for in vivo research Psychopharmacology 190 2007 269 319
18. J.T. Winslow, and K.A. Miczek Habituation of aggressive-behavior in mice - a parametric study Aggress. Behav. 10 1984 103 113
19. G.M. Sankoorikal, K.A. Kaercher, C.J. Boon, J.K. Lee, and E.S. Brodkin A mouse model system for genetic analysis of sociability: C57BL/6J versus BALB/cJ inbred mouse strains Biol. Psychiatry 59 2006 415 423
20. J. Schindelin, I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T. Pietzsch, and et al. Fiji: an open-source platform for biological-image analysis Nat. Methods 9 2012 676 682
21. D. Lin, M.P. Boyle, P. Dollar, H. Lee, E.S. Lein, P. Perona, and et al. Functional identification of an aggression locus in the mouse hypothalamus Nature 470 2011 221 226
22. M.J. Marks, J.B. Burch, and A.C. Collins Genetics of nicotine response in four inbred strains of mice J. Pharmacol. Exp. Ther. 226 1983 291 302
23. J.D. Brioni, A.B. O'Neill, D.J. Kim, and M.W. Decker Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test Eur. J. Pharmacol. 238 1993 1 8
24. M.J. Marks, J.A. Stitzel, and A.C. Collins Genetic influences on nicotine responses Pharmacol. Biochem. Behav. 33 1989 667 678
25. T. Tritto, S.E. McCallum, S.A. Waddle, S.R. Hutton, R. Paylor, A.C. Collins, and et al. Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia Nicotine Tob. Res. 6 2004 145 158
26. K.E. Stevens, W.R. Kem, V.M. Mahnir, and R. Freedman Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice Psychopharmacology 136 1998 320 327
27. C.J. Wilhelm, R.A. Johnson, A.J. Eshleman, and A. Janowsky Lobeline effects on tonic and methamphetamine-induced dopamine release Biochem. Pharmacol. 75 2008 1411 1415
28. R. Redolat, M.C. Oterino, M.C. Carrasco, M.S. Berry, and P.F. Brain Effects of acute administration of nicotine and lobeline on agonistic encounters in male mice Aggress. Behav. 26 2000 376 385
29. R. Redolat, M.C. Oterino, M.C. Carrasco, and P.F. Brain A specific anti-aggressive effect of repeatedly administered lobeline Addict. Biol. 7 2002 301 306
30. M.C. Gomez, M.C. Carrasco, and R. Redolat Differential sensitivity to the effects of nicotine and bupropion in adolescent and adult male OF1 mice during social interaction tests Aggress. Behav. 34 2008 369 379
31. Z. Rolinski, and M. Herbut The importance of central nicotinic receptors in footshock-induced aggression in mice Pol. J. Pharmacol. Pharm. 33 1981 569 576
32. R. Schneider, H.J. Hoffmann, H. Schicknick, and R. Moutier Genetic analysis of isolation-induced aggression. I. Comparison between closely related inbred mouse strains Behav. Neural Biol. 57 1992 198 204
33. K. Nakamura, and M. Kurasawa Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism Eur. J. Pharmacol. 420 2001 33 43
34. M.I. Damaj, S.P. Welch, and B.R. Martin In vivo pharmacological effects of dihydro-beta-erythroidine, a nicotinic antagonist, in mice Psychopharmacology 117 1995 67 73
35. M.E. Avale, P. Faure, S. Pons, P. Robledo, T. Deltheil, D.J. David, and et al. Interplay of beta2∗nicotinic receptors and dopamine pathways in the control of spontaneous locomotion Proc. Natl. Acad. Sci. U. S. A. 105 2008 15991 15996
36. J.A. Davis, and T.J. Gould The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice Psychopharmacology 184 2006 345 352
37. R.S. Coura, A. Cressant, J. Xia, F. de Chaumont, J.C. Olivo-Marin, Y. Pelloux, and et al. Nonaggressive and adapted social cognition is controlled by the interplay between noradrenergic and nicotinic receptor mechanisms in the prefrontal cortex FASEB J. 27 2013 4343 4354
38. S. Granon, P. Faure, and J.P. Changeux Executive and social behaviors under nicotinic receptor regulation Proc. Natl. Acad. Sci. U. S. A. 100 2003 9596 9601
39. S. Fucile, J.M. Matter, L. Erkman, D. Ragozzino, B. Barabino, F. Grassi, and et al. The neuronal alpha6 subunit forms functional heteromeric acetylcholine receptors in human transfected cells Eur. J. Neurosci. 10 1998 172 178
40. S. Vailati, W. Hanke, A. Bejan, B. Barabino, R. Longhi, B. Balestra, and et al. Functional alpha6-containing nicotinic receptors are present in chick retina Mol. Pharmacol. 56 1999 11 19
41. R. Salas, A. Main, D. Gangitano, and M. De Biasi Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit Neuropharmacology 53 2007 863 869
42. I. Morganstern, O. Lukatskaya, S.H. Moon, W.R. Guo, J. Shaji, O. Karatayev, and et al. Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet Psychopharmacology 230 2013 509 524
43. E.D. Levin, F.J. McClernon, and A.H. Rezvani Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization Psychopharmacology 184 2006 523 539
44. C.A. Briggs, and D.G. McKenna Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists Neuropharmacology 37 1998 1095 1102
45. M.R. Picciotto, N.A. Addy, Y.S. Mineur, and D.H. Brunzell It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood Prog. Neurobiol. 84 2008 329 342
46. P. Seth, S. Cheeta, S. Tucci, and S.E. File Nicotinic-serotonergic interactions in brain and behaviour Pharmacol. Biochem. Behav. 71 2002 795 805
47. S. Aznar, V. Kostova, S.H. Christiansen, and G.M. Knudsen Alpha 7 nicotinic receptor subunit is present on serotonin neurons projecting to hippocampus and septum Synapse 55 2005 196 200
48. L. Galindo-Charles, S. Hernandez-Lopez, E. Galarraga, D. Tapia, J. Bargas, J. Garduno, and et al. Serotoninergic dorsal raphe neurons possess functional postsynaptic nicotinic acetylcholine receptors Synapse 62 2008 601 615
49. F. Hernandez-Vazquez, K. Chavarria, J. Garduno, S. Hernandez-Lopez, and S.P. Mihailescu Nicotine increases GABAergic input on rat dorsal raphe serotonergic neurons through alpha7 nicotinic acetylcholine receptor J. Neurophysiol. 112 2014 3154 3163
50. M. Huang, A.R. Felix, D.G. Flood, C. Bhuvaneswaran, D. Hilt, G. Koenig, and et al. The novel alpha7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens Psychopharmacology 231 2014 4541 4551
51. A.T. Seipel, and J.L. Yakel The frequency-dependence of the nicotine-induced inhibition of dopamine is controlled by the alpha7 nicotinic receptor J. Neurochem. 114 2010 1659 1666
52. C.M. de Fiebre, E.M. Meyer, J.C. Henry, S.I. Muraskin, W.R. Kem, and R.L. Papke Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes Mol. Pharmacol. 47 1995 164 171
53. C.A. Briggs, D.J. Anderson, J.D. Brioni, J.J. Buccafusco, M.J. Buckley, J.E. Campbell, and et al. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo Pharmacol. Biochem. Behav. 57 1997 231 241
54. E.M. Meyer, A. Kuryatov, V. Gerzanich, J. Lindstrom, and R.L. Papke Analysis of 3-(4-hydroxy, 2-methoxybenzylidene) anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors J. Pharmacol. Exp. Ther. 287 1998 918 925
55. K.E. Stevens, R. Freedman, A.C. Collins, M. Hall, S. Leonard, M.J. Marks, and et al. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains Neuropsychopharmacology 15 1996 152 162
56. A. Olincy, J.G. Harris, L.L. Johnson, V. Pender, S. Kongs, D. Allensworth, and et al. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia Arch. Gen. Psychiatry 63 2006 630 638
57. T.K. Machu, M.E. Hamilton, T.F. Frye, C.L. Shanklin, M.C. Harris, H. Sun, and et al. Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor J. Pharmacol. Exp. Ther. 299 2001 1112 1119
58. D.H. Yasui, H.A. Scoles, S. Horike, M. Meguro-Horike, K.W. Dunaway, D.I. Schroeder, and et al. 15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain Hum. Mol. Genet. 20 2011 4311 4323
59. C.S. Leblond, J. Heinrich, R. Delorme, C. Proepper, C. Betancur, G. Huguet, and et al. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders PLoS Genet. 8 2012 e1002521
60. F.M. Mikhail, E.J. Lose, N.H. Robin, M.D. Descartes, K.D. Rutledge, S.L. Rutledge, and et al. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders Am. J. Med. Genet. A 155A 2011 2386 2396
61. N. Hoppman-Chaney, K. Wain, P.R. Seger, D.W. Superneau, and J.C. Hodge Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype Clin. Genet. 83 2013 345 351
62. I. Helbig, H.C. Mefford, A.J. Sharp, M. Guipponi, M. Fichera, A. Franke, and et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy Nat. Genet. 41 2009 160 162
63. A.J. Sharp, H.C. Mefford, K. Li, C. Baker, C. Skinner, R.E. Stevenson, and et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures Nat. Genet. 40 2008 322 328
64. K. Fejgin, J. Nielsen, M.R. Birknow, J.F. Bastlund, V. Nielsen, J.B. Lauridsen, and et al. A mouse model that recapitulates cardinal features of the 15q13.3 microdeletion syndrome including schizophrenia- and epilepsy-related alterations Biol. Psychiatry 76 2014 128 137
65. L.F. Martin, and R. Freedman Schizophrenia and the alpha7 nicotinic acetylcholine receptor Int. Rev. Neurobiol. 78 2007 225 246
66. E. Stergiakouli, M. Hamshere, P. Holmans, K. Langley, I. Zaharieva, C.G. de, and et al. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD Am. J. Psychiatry 169 2012 186 194
67. R. Freedman alpha7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia Annu. Rev. Med. 65 2014 245 261
68. K.T. Dineley, A.A. Pandya, and J.L. Yakel Nicotinic ACh receptors as therapeutic targets in CNS disorders Trends Pharmacol. Sci. 36 2015 96 108